Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-08-27

Clinical Trial Update: Treatment of Residual Myopic Refraction After 6 Months on Pseudophakic Patients Using Relex-Smile [NA]

View source ↗

Summary

This clinical trial update notes that enrollment is ongoing for a study evaluating treatment of residual myopic refractive error in pseudophakic patients using …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Relex-Smile

Snippet

Sponsor: Eye Hospital Pristina Kosovo | Conditions: Pseudophakia, Myopia | NA | Status: ENROLLING_BY_INVITATION